| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Zealand Pharma A/S (CO: ZEAL)
ZEAL Technical Analysis
5
| As on 11th Jul 2023 ZEAL SHARE Price closed @ 229.60 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 128.69 & Strong Buy for SHORT-TERM with Stoploss of 104.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ZEALSHARE Price
| Open | 242.00 | Change | Price | % |
| High | 243.20 | 1 Day | -10.20 | -4.25 |
| Low | 228.60 | 1 Week | -15.00 | -6.13 |
| Close | 229.60 | 1 Month | -35.00 | -13.23 |
| Volume | 188421 | 1 Year | 104.40 | 83.39 |
| 52 Week High 283.20 | 52 Week Low 71.95 | ||||
CO Denmark Most Active Stocks
| SAS-DKK | 0.23 | 0.00% |
| SAS | 0.23 | 0.00% |
| TRYG | 134.80 | -6.62% |
| AMBU-B | 103.75 | -4.38% |
| VWS | 179.82 | 2.07% |
| NOVO-B | 1034.60 | -2.56% |
| ALMB | 11.09 | -0.54% |
| GREENH | 10.50 | 1.94% |
| DANSKE | 166.10 | 1.10% |
| BLVIS-A | 0.40 | -18.37% |
CO Denmark Top Gainers Stocks
CO Denmark Top Losers Stocks
| ZEAL Daily Charts |
ZEAL Intraday Charts |
Whats New @ Bazaartrend |
ZEAL Free Analysis |
|
|
ZEAL Important Levels Intraday
| RESISTANCE | 257.73 |
| RESISTANCE | 248.71 |
| RESISTANCE | 243.13 |
| RESISTANCE | 237.56 |
| SUPPORT | 221.64 |
| SUPPORT | 216.07 |
| SUPPORT | 210.49 |
| SUPPORT | 201.47 |
ZEAL Forecast April 2024
| 4th UP Forecast | 315.54 |
| 3rd UP Forecast | 287.98 |
| 2nd UP Forecast | 270.94 |
| 1st UP Forecast | 253.91 |
| 1st DOWN Forecast | 205.29 |
| 2nd DOWN Forecast | 188.26 |
| 3rd DOWN Forecast | 171.22 |
| 4th DOWN Forecast | 143.66 |
ZEAL Weekly Forecast
| 4th UP Forecast | 250.41 |
| 3rd UP Forecast | 243.74 |
| 2nd UP Forecast | 239.61 |
| 1st UP Forecast | 235.49 |
| 1st DOWN Forecast | 223.71 |
| 2nd DOWN Forecast | 219.59 |
| 3rd DOWN Forecast | 215.46 |
| 4th DOWN Forecast | 208.79 |
ZEAL Forecast2024
| 4th UP Forecast | 647.86 |
| 3rd UP Forecast | 513.72 |
| 2nd UP Forecast | 430.81 |
| 1st UP Forecast | 347.89 |
| 1st DOWN Forecast | 111.31 |
| 2nd DOWN Forecast | 28.39 |
| 3rd DOWN Forecast | -54.52 |
| 4th DOWN Forecast | -188.66 |
Zealand Pharma A/S ( CO Denmark Symbol : ZEAL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ZEAL Business Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Address: Sydmarken 11, Copenhagen, Denmark, 2860
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service